Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06812936Phase 1Not yet recruiting
Phase 1, randomised, single-blind trial (2 arms), sponsored by University of Baghdad. Primary endpoint: Visual Analog Scale Pain Score at 5 days. Planned start Feb 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06812936.